Corrigendum: Enhancing AAV-microdystrophin gene therapy after repeat dosing by blocking phagocytosis

Corrigendum: Enhancing AAV-microdystrophin gene therapy after repeat dosing by blocking phagocytosis

Saved in:

Bibliographic Details
Main Authors:	Rita Spathis, Deeva Robles Kuriplach, Sabrina Narvesen, Matthew Eybs, Karen Huang, Steven Torres, Madison King, Elizabeth Bagley, Pia Elustondo, Michael W. Lawlor, Kanneboyina Nagaraju, Melissa Morales
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-03-01
Series:	Frontiers in Immunology
Subjects:	AAV9 mdx Duchenne muscular dystrophy DMD gene therapy immune response
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1593193/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Dux Is Dispensable for Skeletal Muscle Regeneration: A Study Inspired by a “Red Flagged” Publication and Editorial Oversight
by: Kenric Chen, et al.
Published: (2025-05-01)

Adeno‐Associated Virus 8 and 9 Myofibre Type/Size Tropism Profiling Reveals Therapeutic Effect of Microdystrophin in Canines
by: Matthew J. Burke, et al.
Published: (2025-02-01)

Enhanced expression of dystrophin, IGF-1, CD44 and MYH3 in plasma and skeletal muscles including diaphragm of mdx mice after oral administration of Neu REFIX beta 1,3-1,6 glucan
by: Senthilkumar Preethy, et al.
Published: (2025-02-01)

Importância do camundongo mdx na fisiopatologia da distrofia muscular de Duchenne The importance of mdx mouse in the pathophysiology of Duchenne's muscular distrophy
by: Sandra Lopes Seixas, et al.
Published: (1997-09-01)

Stages of research and development of therapeutic approaches for Duchenne myodystrophy. Part I: the period before etiotropic approaches introduction
by: K. S. Kochergin-Nikitskiy, et al.
Published: (2024-03-01)

Stages of research and development of therapeutic approaches for Duchenne myodystrophy. Part II: etiotropic approaches
by: K. S. Kochergin-Nikitskiy, et al.
Published: (2024-05-01)

Expanding the Molecular Genetic Landscape of Dystrophinopathies and Associated Phenotypes
by: Katja Neuhoff, et al.
Published: (2024-11-01)

Transcriptomic profiling of skeletal muscle in the DMD mdx rat model of Duchenne muscular dystrophy
by: Abdolvahab Ebrahimpour Gorji, et al.
Published: (2025-08-01)

Intrinsic Muscle Stem Cell Dysfunction Contributes to Impaired Regeneration in the mdx Mouse
by: Marie E. Esper, et al.
Published: (2025-02-01)

Application of long-read sequencing in the diagnosis of Duchenne/Becker muscular dystrophy: unveiling complex structural variations and deep intronic mutations
by: Yixuan Chu, et al.
Published: (2025-07-01)

Modern methods of therapy of Duchenne muscular dystrophy: literature review with a clinical case
by: S. B. Artemyeva, et al.
Published: (2024-01-01)

Positive experience in treating patients with Duchenne muscular dystrophy caused by a nonsense mutation: family clinical case
by: L. S. Kraeva, et al.
Published: (2024-09-01)

Possibility of exon skipping therapy for Duchenne muscular dystrophy in Russian patients: present and future
by: E. V. Zinina, et al.
Published: (2024-09-01)

DWORF expression is reduced in a large animal model of Duchenne muscular dystrophy
by: Aaron M. Gibson, et al.
Published: (2025-06-01)

Change in the spectrum of detected mutations in the <I>DMD</I> gene depending on the methodological capabilities of the laboratory
by: E. V. Zinina, et al.
Published: (2023-03-01)

Improving the therapeutic efficacy of gene therapy for duchenne muscular dystrophy (DMD) by evaluating and managing inflammation
by: Kadalraja Raghavan, et al.
Published: (2025-06-01)

Mineralocorticoid receptor antagonists reduce inflammatory signaling independent of myofiber mineralocorticoid receptor
by: Jeovanna Lowe, et al.
Published: (2025-12-01)

Duchenne muscular dystrophy - disease characterization and emergent genetic therapy - literature review
by: Anna Teresa Michalska, et al.
Published: (2025-07-01)

Duchenne muscular dystrophy: an historical treatment review
by: Lineu Cesar Werneck, et al.

Orthopaedic Management in Duchenne Muscular Dystrophy
by: Uma Balachandran, BA, et al.
Published: (2025-02-01)

A combinatorial oligonucleotide therapy to improve dystrophin restoration and dystrophin-deficient muscle health
by: Young Jae Moon, et al.
Published: (2025-09-01)

Circulatory CCL2 distinguishes Duchenne muscular dystrophy dogs
by: Dennis O. Pérez-López, et al.
Published: (2025-03-01)

The association of hand grip strength with functional measures in non-ambulatory children with Duchenne muscular dystrophy
by: Numan Bulut, et al.
Published: (2019-12-01)

Living with Duchenne Muscular Dystrophy Beyond the Physical Implications: Cognitive Features, Psychopathology Aspects, and Psychosocial Resources—A Narrative Review
by: Federica Tizzoni, et al.
Published: (2025-06-01)

APE1/Ref‐1 inhibition via APX3330 lowers monocyte/macrophage infiltration without ameliorating the structure and function of dystrophic mdx hindlimb muscles
by: Hannah Lalunio, et al.
Published: (2025-08-01)

Complexities of care in a pediatric patient with epidermolysis bullosa acquisita and duchenne muscular dystrophy: a case report
by: Khayry Al-Shami, et al.
Published: (2025-07-01)

Regional anesthesia and muscle-wasting diseases in pediatrics: A focused educational review
by: Amr Elhamrawy, et al.
Published: (2025-01-01)

Optimized genomic editing of a common Duchenne muscular dystrophy mutation in patient-derived muscle cells and a new humanized mouse model
by: Mateusz Z. Durbacz, et al.
Published: (2025-06-01)

Long-term, age-associated activity quantification in the DE50-MD dog model of Duchenne muscular dystrophy
by: Kamila Karimjee, et al.
Published: (2025-07-01)

Cardiac MRI in Duchenne and Becker Muscular Dystrophy
by: Manu Santhappan Girija, et al.
Published: (2024-10-01)

AAV-shDUX4 provides short-term benefits but limited long-term efficacy in a DUX4 mouse model of FSHD
by: S. Sohn, et al.
Published: (2025-09-01)

Immunologic investigations into transgene directed immune-mediated myositis following delandistrogene moxeparvovec gene therapy
by: Rachael A. Potter, et al.
Published: (2025-01-01)

Cardiac Histopathology in Duchenne Muscular Dystrophy Demonstrates Diffuse Fibrofatty Replacement of the Myocardium
by: Andrea Breaux, et al.
Published: (2024-11-01)

Guillaume-Benjamin Duchenne: a miserable life dedicated to science
by: Péricles MARANHÃO-FILHO, et al.

Pain characterization in Duchenne muscular dystrophy
by: Talita Dias da Silva, et al.

Comprehensive management of acute respiratory distress in a 13-year-old female with Duchenne muscular dystrophy: a case report
by: Khayry Al-Shami, et al.
Published: (2025-07-01)

Successful strategy of comprehensive pre-implantation genetic testing for Duchenne muscular dystrophy and chromosome balance using karyomapping and fluorescent PCR
by: Suchada Mongkolchaipak, et al.
Published: (2021-10-01)

The behavioural consequences of dystrophinopathy
by: Minou A. T. Verhaeg, et al.
Published: (2025-02-01)

ST-segment elevation acute coronary syndrome in a child with Duchenne muscular dystrophy: a case report
by: Z. G. Tatarintseva, et al.
Published: (2024-12-01)

Adiponectin-receptor agonism prevents right ventricular tissue pathology in a mouse model of Duchenne muscular dystrophy
by: Shivam Gandhi, et al.
Published: (2025-09-01)